An Internet based medical
device regulatory service company.
Regulatory Assistance with medical devices and the U.S. FDA.
Delphi Consulting Group (DCG) provides comprehensive medical
device U.S. FDA regulatory services. The following is a brief overview of
services:
Key Services:
Premarket Notifications- DCG provides research, writing,
testing monitoring, follow-through and/or review of FDA 513g, 510(k)s,
Pre-IDE, IDE, De Novo and PMA
submission. DCG produced submissions have often resulted in less than
normal review time. Submissions have been completed and released to
market for device manufactures located worldwide.
Consulting Activities and Product Experience.
NRC License - DCG has produced licenses submissions for
sealed sources and Brachytheray devices, CFR 10 Section 30.32XX and CFR 10
Part 71, packaging and transportation Radioactive materials.
Biocompatibility and Sterilization Validations - Product
biocompatibility and sterilization validations and re-sterilization
validations. Work with testing laboratories to write protocols, monitor
testing and completion reports.
EMI and Safety Standards Testing - Work with testing
laboratories to write protocols, monitor testing and completion reports.
Act as Agent for UL Listing. Monitor testing laboratory activities and provide
engineering feedback.
Replies to FDA Form 483, Warning Letters and Seizure Actions -- DCG has extensive experience with preparing strategy for reply and
follow up actions.
Reuse of Single Use Devices - Premarket submissions for
Hospitals and Third Party Re-Processors to ensure compliance with regulations
and laws.
U.S. Agent - DCG provides U.S. Agent Services for Foreign
Establishments per 21 CFR 807.40. DCG is listed with the FDA as a
"United States Agent for Devices" as defined in Section 417 of the
Modernization Act of 1997. Foreign companies holding U.S. FDA release to
market for a medical device offered for sale in the U.S. must have a U.S.
Agent. Please
note that we do NOT provide FDA Agent representation forFOODcompanies.
Fee Schedules:
Click
Here for a very generalized budget review of consulting and FDA fees for
common device submissions.
Capabilities
The following is abbreviated list of general capabilities and device
experience.
Consulting Activities
FDA "Release to Market" via 510(k), IDE and PMA pathways
CGMP Quality System Development
CGLP Quality System Development
Design Review and Records Facilitation
Regulatory Project Management
Investment regulatory and risk review and analysis
US and International Safety Standards review and listing, i.e., UL and
IEC 60601
Assistance with FDA & State FDA Inspection, replies to FDA Form 483
notices
Regulatory Retainer for small to medium size companies for general FDA
regulatory needs
Product Experience [abbreviated list]
Endotracheal and Tracheal tubes
Perfusion devices and tubing sets
Heart, By-Pass pumps and patient sets
Orthopedic devices
Oncology devices
Catheters; Angioplasty, Vascular, Embolectomy and Monitoring
Lasers; YAG, Argon and CO2
Stents
Syringes: Standard and Pre-Filled
Instrumentation; Monitors, Diagnostics, Life Support